These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39159863)

  • 1. Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: A preliminary study.
    Zhang Y; Zhao Y; Zhang J; Gao Y; Gao X; Li S; Chang C; Yang G
    J Proteomics; 2024 Sep; 308():105279. PubMed ID: 39159863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Profiling of Extracellular Vesicles Derived from Cerebrospinal Fluid of Alzheimer's Disease Patients: A Pilot Study.
    Muraoka S; Jedrychowski MP; Yanamandra K; Ikezu S; Gygi SP; Ikezu T
    Cells; 2020 Aug; 9(9):. PubMed ID: 32854315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic and biological profiling of extracellular vesicles from Alzheimer's disease human brain tissues.
    Muraoka S; DeLeo AM; Sethi MK; Yukawa-Takamatsu K; Yang Z; Ko J; Hogan JD; Ruan Z; You Y; Wang Y; Medalla M; Ikezu S; Chen M; Xia W; Gorantla S; Gendelman HE; Issadore D; Zaia J; Ikezu T
    Alzheimers Dement; 2020 Jun; 16(6):896-907. PubMed ID: 32301581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-enriched plasma proteome is significantly altered in Alzheimer's disease.
    Guo Q; Ping L; Dammer EB; Duong DM; Yin L; Xu K; Shantaraman A; Fox EJ; Golde TE; Johnson ECB; Roberts BR; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2024 Oct; 19(1):67. PubMed ID: 39380021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study.
    Chatterjee M; Özdemir S; Kunadt M; Koel-Simmelink M; Boiten W; Piepkorn L; Pham TV; Chiasserini D; Piersma SR; Knol JC; Möbius W; Mollenhauer B; van der Flier WM; Jimenez CR; Teunissen CE; Jahn O; Schneider A
    Alzheimers Dement; 2023 Nov; 19(11):4828-4840. PubMed ID: 37023079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: a pilot study.
    Sattarov R; Havers M; Orbjörn C; Stomrud E; Janelidze S; Laurell T; Mattsson-Carlgren N
    Sci Rep; 2024 Oct; 14(1):25419. PubMed ID: 39455624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
    Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
    Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscale flow cytometry-based quantification of blood-based extracellular vesicle biomarkers distinguishes MCI and Alzheimer's disease.
    Dayarathna T; Roseborough AD; Gomes J; Khazaee R; Silveira CRA; Borron K; Yu S; Coleman K; Jesso S; Finger E; MacDonald P; Borrie M; Wells J; Bartha R; Zou G; Whitehead SN; Leong HS; Pasternak SH
    Alzheimers Dement; 2024 Sep; 20(9):6094-6106. PubMed ID: 38958575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer's disease patients and cognitively normal individuals.
    Boyer E; Deltenre L; Dourte M; Colmant L; Paître E; Sleegers K; Suelves N; Hanseeuw B; Kienlen-Campard P
    Alzheimers Res Ther; 2024 Jun; 16(1):141. PubMed ID: 38943196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease.
    Modeste ES; Ping L; Watson CM; Duong DM; Dammer EB; Johnson ECB; Roberts BR; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2023 Jul; 18(1):48. PubMed ID: 37468915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease brain-derived extracellular vesicles reveal altered synapse-related proteome and induce cognitive impairment in mice.
    Bodart-Santos V; Pinheiro LS; da Silva-Junior AJ; Froza RL; Ahrens R; Gonçalves RA; Andrade MM; Chen Y; Alcantara CL; Grinberg LT; Leite REP; Ferreira ST; Fraser PE; De Felice FG
    Alzheimers Dement; 2023 Dec; 19(12):5418-5436. PubMed ID: 37204850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimized method for enrichment of whole brain-derived extracellular vesicles reveals insight into neurodegenerative processes in a mouse model of Alzheimer's disease.
    Hurwitz SN; Sun L; Cole KY; Ford CR; Olcese JM; Meckes DG
    J Neurosci Methods; 2018 Sep; 307():210-220. PubMed ID: 29894726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicle proteome unveils cathepsin B connection to Alzheimer's disease pathogenesis.
    Yuyama K; Sun H; Fujii R; Hemmi I; Ueda K; Igeta Y
    Brain; 2024 Feb; 147(2):627-636. PubMed ID: 38071653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
    Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
    Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of Neurodegenerative Microglia Signature in Brain-Derived Extracellular Vesicles Isolated from Alzheimer's Disease Mouse Models.
    Muraoka S; Jedrychowski MP; Iwahara N; Abdullah M; Onos KD; Keezer KJ; Hu J; Ikezu S; Howell GR; Gygi SP; Ikezu T
    J Proteome Res; 2021 Mar; 20(3):1733-1743. PubMed ID: 33534581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicles: A Possible Link between HIV and Alzheimer's Disease-Like Pathology in HIV Subjects?
    Kodidela S; Gerth K; Haque S; Gong Y; Ismael S; Singh A; Tauheed I; Kumar S
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.
    Dayon L; Wojcik J; Núñez Galindo A; Corthésy J; Cominetti O; Oikonomidi A; Henry H; Migliavacca E; Bowman GL; Popp J
    J Alzheimers Dis; 2017; 60(4):1641-1652. PubMed ID: 29125490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human neural cell type-specific extracellular vesicle proteome defines disease-related molecules associated with activated astrocytes in Alzheimer's disease brain.
    You Y; Muraoka S; Jedrychowski MP; Hu J; McQuade AK; Young-Pearse T; Aslebagh R; Shaffer SA; Gygi SP; Blurton-Jones M; Poon WW; Ikezu T
    J Extracell Vesicles; 2022 Jan; 11(1):e12183. PubMed ID: 35029059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.